Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $100000.0.

  • Harvard Bioscience's Tax Provisions fell 6784.57% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $170000.0, marking a year-over-year decrease of 7966.51%. This contributed to the annual value of $740000.0 for FY2024, which is 1385.33% down from last year.
  • Per Harvard Bioscience's latest filing, its Tax Provisions stood at $100000.0 for Q3 2025, which was down 6784.57% from $30000.0 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Tax Provisions ranged from a high of $1.3 million in Q4 2022 and a low of -$1.3 million during Q3 2022
  • Over the past 5 years, Harvard Bioscience's median Tax Provisions value was $210000.0 (recorded in 2024), while the average stood at $133736.8.
  • Examining YoY changes over the last 5 years, Harvard Bioscience's Tax Provisions showed a top increase of 55045.05% in 2022 and a maximum decrease of 82000.0% in 2022.
  • Quarter analysis of 5 years shows Harvard Bioscience's Tax Provisions stood at $541000.0 in 2021, then skyrocketed by 135.12% to $1.3 million in 2022, then tumbled by 43.79% to $715000.0 in 2023, then fell by 24.48% to $540000.0 in 2024, then plummeted by 81.48% to $100000.0 in 2025.
  • Its last three reported values are $100000.0 in Q3 2025, $30000.0 for Q2 2025, and -$500000.0 during Q1 2025.